Darbepoetin Alfa in Patients With Anemic Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
Clinical trial NCT01362140 · COMPLETED
Trial details
- NCT number
- NCT01362140
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-21
- Primary completion
- 2015-02-11
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.